Discover B2B leads for Pharmaceuticals industry
Identify and research relevant prospects for B2B lead generation on Pharmaceuticals sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 7 in our database
Found 210 in our records
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 3, 2024
Venture Stage: Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity, Seed, Venture
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
HQ: New York, New York, United States
Pfizer
Pfizer is a biopharmaceutical company that provideShow more...s affordable access to safe, effective medicines and health care services.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Sep 9, 2024
Founded Date: 1849
Number of Exits: 19
Company Type: For Profit
Stock Symbol: NYSE:PFE
Operating Status: Active
Investor Type: Corporate Venture Capital, Venture Capital
42 Emails
0 Phones
Main email format: sarah.smith@pfizer.com (92.1%)
-
Rebecca Hamm
Senior Director, Communications
r**********m@pfizer.com
-
Christopher Conner
US Field Medical Excellence Vaccines + Antivirals
c****************r@pfizer.com
-
Adam Guhle
Oncology Category Lead
a********e@pfizer.com
-
Neil Campbell
Senior Director, Pfizer Global Supply
n***********l@pfizer.com
-
Mathieu Poirier
Therapeutic Area Lead, Global Commercial Access Partnerships
m*************r@pfizer.com
-
Jennifer Lafontaine
VP, Head of Oncology Medicinal Chemistry
j*****************e@pfizer.com
-
Mike Mcdermott
Chief Global Supply Officer, Executive Vice President
m************t@pfizer.com
-
Sally Susman
Executive Vice President and Chief Corporate Affairs Officer
s**********n@pfizer.com
-
Kathrin Jansen
Senior Vice President and Head of Vaccine R&D
k************n@pfizer.com
-
Paul Fitzgerald
Energy, Utilities and Facilities Services Lead
p*************d@pfizer.com
-
Julie Jenson
Director Corporate Responsibility
j***********n@pfizer.com
-
Suzanna Ladas
Source to Contract Operations
s***********s@pfizer.com
-
David Breen
Site Leader, Algete, Madrid, Spain
d*********n@pfizer.com
-
Alfredo Linares
Vice President, People Experience, Organizational Development and Communications, PGS Division
a*************s@pfizer.com
-
Nooshin Rahimi
Professional Healthcare Representative
n************i@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k***********i@pfizer.com
-
Prabhu Kundurthy
p**************y@pfizer.com
-
Steven Ph.D.
s********x@pfizer.com
-
Nina Jochnowitz
Business Analyst
n*************z@pfizer.com
-
Loucineh Mardirossian
Director, Communications
l*******************n@pfizer.com
-
Keith Jago
k********o@pfizer.com
-
Shaan Gandhi
Board Member
s**********i@pfizer.com
-
Cindy Schmidt
c***********t@pfizer.com
-
letizia greggi
l************i@pfizer.com
-
Azzurra Ravizza
a*************a@pfizer.com
-
Jane Kuczma
Director, Clinical Data Management
j*********a@pfizer.com
-
Agnes Hong
a********g@pfizer.com
-
Heather Cisek
h***********k@pfizer.com
-
Matthew Badland
m*************d@pfizer.com
-
Yulia Ivanova
y***********a@pfizer.com
-
Dario Bottaro
d***********o@pfizer.com
-
Brigitte TEXIER
b*************r@pfizer.com
-
Ron Cherepuschak
r**************k@pfizer.com
-
Johanna
j*****a@pfizer.com
-
Rasid Kamal
r*********l@pfizer.com
-
Liesbet Symoens
l*************s@pfizer.com
-
Erica Cline Reading
e***********g@pfizer.com
-
Jaclyn McNelis, MSHRM
j************s@pfizer.com
-
Christine Mckenna
Consultant
c***************a@pfizer.com
-
Juan Borger
j*********r@pfizer.com
-
Kamran Ansari
VP, Head of Clinical Development Operations
k****n@pfizer.com
-
Prabhu Kundurthy
prabhu@pfizer.com
-
General Inquiries
info@pfizer.com
HQ: Cambridge, Cambridgeshire, United Kingdom
AstraZeneca
AstraZeneca is a pharmaceutical company that discoShow more...vers, develops, manufactures, and markets prescription medicines.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active
27 Emails
0 Phones
Main email format: sarah.smith@astrazeneca.com (100.0%)
-
Marc Dunoyer
Chief Strategy Officer
m**********r@astrazeneca.com
-
Richard Gallo
Oncology Contract Strategy Manager
r***********o@astrazeneca.com
-
Nabil Dharsi
Medical Science Liaison, Hematology
n**********i@astrazeneca.com
-
Dan Wygal
Executive Director of Contract and Channel Strategy
d*******l@astrazeneca.com
-
Claudia Lamp
Contract Sr Patient Safety Scientist
c**********p@astrazeneca.com
-
Tom Keith-Roach
President, Astrazeneca UK
t*************h@astrazeneca.com
-
Mary Richardson
Global Publications Director, OBU
m*************n@astrazeneca.com
-
Matthew Roe
VP, Head of Early Clinical Development - Cardiovascular, Renal, and Metabolic
m*********e@astrazeneca.com
-
Jennifer Schmoll
Global Marketing Director-Diabetes
j**************l@astrazeneca.com
-
Lee Bennett
Associate Regulatory Project Director
l*********t@astrazeneca.com
-
Jasmine Jansens
Clinical Site Monitor
j*************s@astrazeneca.com
-
Stephanie Kenney
Global Head of Corporate Affairs, Cardiovascular Renal and Metabolism
s********************i@astrazeneca.com
-
Giovanni Melillo
Vice President - Immuno-oncology, Global Medical Affairs
g**************o@astrazeneca.com
-
Karina Estevez
Human Resources Global Graduate Associate
k************z@astrazeneca.com
-
Francesco Dazzi
Professor of Regenerative and Haematological Medicine - KHP Lead for Cellular Therapies
f*************i@astrazeneca.com
-
Graham Belfield
g*************d@astrazeneca.com
-
Tony Pusic
t********c@astrazeneca.com
-
Ronnie Stevens
r************s@astrazeneca.com
-
Miriam Wu
m*******u@astrazeneca.com
-
James Thomas Coates
Principal
j**********s@astrazeneca.com
-
Chandler Chen
Investment Director, Healthcare Fund
c***********n@astrazeneca.com
-
Jelena Saillard
j*************d@astrazeneca.com
-
Debasree Purkayastha
d******************a@astrazeneca.com
-
Shameen Afif-Rider
s****************r@astrazeneca.com
-
Wilbur Washington
Oncology Senior Sales Specialist - Hematology/Solid Tumor
w***************n@astrazeneca.com
-
General Inquiries
contact@astrazeneca.com
-
General Inquiries
help@astrazeneca.com
HQ: Basel, Basel-Stadt, Switzerland
Roche
Roche is a pharmaceutical and diagnostics company Show more...that focuses on improving people’s lives.
HQ: Basel, Basel-Stadt, Switzerland
Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active
30 Emails
0 Phones
Main email format: sarah.smith@roche.com (100.0%)
-
Jason Hall
Senior Business Analyst
j********l@roche.com
-
Thomas Schinecker
t***************r@roche.com
-
Brad Moore
b********e@roche.com
-
Andre Hoffmann
a************n@roche.com
-
Darla Ramsey
d**********p@roche.com
-
Kevin Bylinski
k************i@roche.com
-
Abed Sabra
a********a@roche.com
-
Nikolce Gjorevski
n***************i@roche.com
-
David Barton
d********1@roche.com
-
Mark Adam
m*******m@roche.com
-
Andrzej Dobrowolski
a*****************i@roche.com
-
Tristin Martin
t************n@roche.com
-
Ivana Vodopivec
i*************c@roche.com
-
William Fraser
w************r@roche.com
-
Björn Itrich
b*********h@roche.com
-
Martin Erschbamer
m***************r@roche.com
-
Anand Vairavan
a************n@roche.com
-
Tim Kuruvilla
Investment Associate
t***********a@roche.com
-
Sanju Sudhakar
s************r@roche.com
-
Szymon Arkuszewski
s****************i@roche.com
-
Mattia Giobbi
m***********i@roche.com
-
Krzysztof Wisniewski
k******************i@roche.com
-
Judy Ney
j******y@roche.com
-
Unclassified inbox
patientcare@roche.com
-
Unclassified inbox
new_zealand.dia_communications@roche.com
-
Unclassified inbox
ireland.drug_surveillance_centre@roche.com
-
General Inquiries
illovo.medinfo@roche.com
-
Unclassified inbox
joerg.kazenwadel@roche.com
-
Unclassified inbox
klaus.christensen@roche.com
-
General Inquiries
mississauga.canada_medinfo@roche.com
HQ: New York, New York, United States
Bristol-Myers Squibb
Bristol-Myers Squibb engages in the discovery, devShow more...elopment, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals.
HQ: New York, New York, United States
Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals
Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital
26 Emails
0 Phones
Main email format: sarah.smith@bms.com (95.2%)
-
John damonti
Foundation President
d******j@bms.com
-
Ron Behling
r************g@bms.com
-
Devin Carsdale
d************e@bms.com
-
Suketu Desai
s**********i@bms.com
-
Zelalem Demere
z************e@bms.com
-
Eva Dion
e******n@bms.com
-
Dina Akbar
d********r@bms.com
-
Jaya Saigal
j*********l@bms.com
-
Danish Sheikh
d***********h@bms.com
-
Trisha Putro
t**********o@bms.com
-
Xue Li
x****i@bms.com
-
Gianina Meltzer
Senior Manager, Regulatory Affairs (Oncology)
g*************r@bms.com
-
Zachary Cain
Associate Director, Payer Marketing at Bristol-Myers Squibb
z**********n@bms.com
-
Zheng Yang
Scientist
z********g@bms.com
-
Herve Bertacchi
h*************i@bms.com
-
Ming Lu
Vice President Clinical Pharmacology
m*****u@bms.com
-
Sonja Heintz
s**********z@bms.com
-
Torsten Schanze
t*************e@bms.com
-
Patricia Gaul
p***********l@bms.com
-
Vanessa Mariani
v****************a@bms.com
-
Emmanuel Chantelot
e****************t@bms.com
-
Ha Dang
h*****g@bms.com
-
Maribelis Ruiz
m************z@bms.com
-
General Inquiries
hello@bms.com
-
General Inquiries
contact@bms.com
-
Legal Department
legal@bms.com
HQ: New York, New York, United States
Owkin
Owkin is an AI precision medicine company with a vShow more...ision to find the right drug for every patient.
HQ: New York, New York, United States
Specialized In: AI & Machine Learning, Pharmaceuticals, Healthcare SaaS, SaaS
Business Type: Private
Employees: 251-500
Rounds: Series B
Last Investment Activity: Mar 26, 2024
Founded Date: 2016
Company Type: For Profit
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@owkin.com (50.0%)
-
Thomas Clozel
Co-Founder & CEO
tc@owkin.com
-
Thomas Clozel
Co-Founder & CEO
t***********l@owkin.com
-
Gilles Wainrib
Founder
gw@owkin.com
-
Darius Meadon
Chief Marketing Officer
d***********n@owkin.com
-
Antonia Twiston-Davies
a************r@owkin.com
-
General Inquiries
hello@owkin.com
-
Customer Service
support@owkin.com
-
General Inquiries
contact@owkin.com
-
Sales Department
sales@owkin.com
-
Legal Department
legal@owkin.com
HQ: Salt Lake City, Utah, United States
Myriad Genetics
Myriad Genetics discovers, develops, and commerciaShow more...lizing novel therapies for the treatment of cancer.
HQ: Salt Lake City, Utah, United States
Specialized In: Biotechnology, Pharmaceuticals
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 1991
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:MYGN
Operating Status: Active
8 Emails
0 Phones
Main email format: sarah.smith@myriad.com (50.0%)
-
Patrick Burke
EVP of Strategy and Innovation
p***********e@myriad.com
-
Dale Muzzey
Vice President of Bioinformatics
d*****y@myriad.com
-
Jerry Lanchbury
CSO
-
Sam Raha
Chief Operating Officer
-
Bryan Riggsbee
EVP Chief Financial Officer
-
Michelle Strecker
User Experience Designer III
-
Kevin Kimberlin
Co-Founder
-
Mark Skolnick
CSO
-
Jason Tang
Digital Project Manager
-
General Inquiries
info@myriad.com
-
Investor Relations
investor@myriad.com
-
Customer Service
support@myriad.com
-
General Inquiries
contact@myriad.com
-
General Inquiries
help@myriad.com
-
Unclassified inbox
cscomments@myriad.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.